Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Researchers have developed a new artificial intelligence-based approach for detecting fatty deposits inside coronary arteries using optical coherence tomography (OCT) images.
Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
Researchers at the University of Arkansas have developed an artificial-intelligence diagnostic tool to detect masked hypertension.
Engineers at Stanford University have developed a high-efficiency, battery/solar-operated, autonomous microscope with integrated artificial intelligence that automatically diagnoses malaria in blood smears
Researchers detail a machine learning model that dramatically accelerates the manufacturing timeline of monoclonal antibodies.
Research reveals distinct patterns of structural changes in patients with Parkinson’s disease, multiple sclerosis, and traumatic brain injury.
SEOUL, South Korea, Feb. 6, 2026 /PRNewswire/ — Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that its software solution, Neurophet AQUA AD Plus, a comprehensive neuroimaging analysis solution for clinical evaluation related to Alzheimer’s disease, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter CGM.
RevealDX’s software analyses CT scans and assigns lung nodules with a Malignancy Similarity Index score to aid in lung cancer diagnosis.